Abram Scientific, a medical device company focused on advancing next-generation coagulation diagnostics, today announced the closing of a $11.75 million Series A financing round. The round was led by ...
The new funding will accelerate the development of a portable diagnostic platform to enhance care for bleeding disorders and critical care medicine.
Alachua Chronicle on MSN
Houston, we have a problem: UF study points to clotting glitch in space
A recent study by University of Florida Health scientists, published in the journal Biomedicines, reveals a space oddity — ...
Market valued at $1.45B in 2024 grows at 10.4% CAGR driven by biocompatible hemostatic solutions in surgical and trauma ...
Morning Overview on MSN
World’s 1st targeted sepsis treatment hailed as potential lifesaving breakthrough
Grand Pharmaceutical Group Limited announced that its experimental drug STC3141 met the primary clinical endpoint in a Phase II trial conducted across sites in China, delivering a statistically ...
DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- The global pharmaceutical supply chain is currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results